Welcome to Pneumolabs
Pneumolabs is a UK based company that provides high quality contract research to progress compounds from hit identification through to lead optimisation. We have a track record of successfully advancing drug candidates to clinical evaluation as well as several scientific publications.
Our greatest asset is our people. Our team of experienced scientists bring in a wealth of experience from the pharmaceutical industry, enabling us to advise our clients on the best model for their desired outcome and tailor our services to our clients’ needs. We offer flexibility, open communication, innovative approaches, willingness to validate new models as well as a rapid and efficient service.
Get In Touch
For further information about our services, or to discuss setting up a new disease model, please contact us using the details below.
Our latest research model involves exposure to the protein from the fungal allergen Alternaria alternata. Data to follow shortly.
Inflammatory diseases are increasing in prevalence around the globe and affect millions of people annually, and so, stemming from our initial expertise in respiratory disease, our models have expanded to cover a broad spectrum of inflammatory based conditions.
We can offer a variety of research models in the field of inflammation, such as respiratory, gastrointestinal and ocular diseases, as well as models of infection, and pharmacokinetic screening.
We are always open to discussing new models specific to your requirements.
- Pulmonary Fibrosis
- Pulmonary Arterial Hypertension
- Sysmex XT – 2000IV
- Luminex MAGPIX® Analysis
- Smoke-induced lung inflammation
- Pulmonary infection
- PK Screening
- Ulcerative Colitis/ Intestinal Fibrosis
- Nasal inflammation
- Ozone-induced lung inflammation
- Acute lung injury
- Asthma exacerbation (Alternaria)
- Asthma exacerbation (influenza)
- Asthma (steroid sensitive)